Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 277

1.

Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy.

Weinberg A, Tierney C, Kendall MA, Bosch RJ, Patterson-Bartlett J, Erice A, Hirsch MS, Polsky B; AIDS Clinical Trials Group 360 Team.

J Infect Dis. 2006 Feb 15;193(4):488-93. Epub 2006 Jan 3.

PMID:
16425127
[PubMed - indexed for MEDLINE]
Free Article
2.

Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.

Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.

HIV Med. 2004 Nov;5(6):407-14.

PMID:
15544692
[PubMed - indexed for MEDLINE]
3.

Cytomegalovirus viremia, mortality, and end-organ disease among patients with AIDS receiving potent antiretroviral therapies.

Wohl DA, Zeng D, Stewart P, Glomb N, Alcorn T, Jones S, Handy J, Fiscus S, Weinberg A, Gowda D, van der Horst C.

J Acquir Immune Defic Syndr. 2005 Apr 15;38(5):538-44.

PMID:
15793363
[PubMed - indexed for MEDLINE]
4.

Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.

Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.

J Infect Dis. 2005 Mar 15;191(6):873-80. Epub 2005 Jan 31.

PMID:
15717261
[PubMed - indexed for MEDLINE]
Free Article
5.

Inconsistent reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy.

Weinberg A, Wohl DA, Barrett RJ, van der Horst C.

J Infect Dis. 2001 Sep 15;184(6):707-12. Epub 2001 Jul 30.

PMID:
11517431
[PubMed - indexed for MEDLINE]
Free Article
6.

Human immunodeficiency virus-infected patients receiving highly active antiretroviral therapy maintain activated CD8+ T cell subsets as a strong adaptive immune response to cytomegalovirus.

Villacres MC, Lacey SF, La Rosa C, Krishnan R, Auge C, Longmate J, Zaia JA, Leedom JM, Diamond DJ.

J Infect Dis. 2001 Aug 1;184(3):256-67. Epub 2001 Jul 10.

PMID:
11443550
[PubMed - indexed for MEDLINE]
Free Article
7.

HIV patients on antiretroviral therapy have high frequencies of CD8 T cells specific for Immediate Early protein-1 of cytomegalovirus.

Stone SF, Price P, Khan N, Moss PA, French MA.

AIDS. 2005 Mar 24;19(6):555-62.

PMID:
15802973
[PubMed - indexed for MEDLINE]
8.

Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.

Keane NM, Price P, Stone SF, John M, Murray RJ, French MA.

AIDS Res Hum Retroviruses. 2000 Dec 10;16(18):1991-6.

PMID:
11153082
[PubMed - indexed for MEDLINE]
9.

Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.

Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA; A5030 Study Team.

HIV Clin Trials. 2009 May-Jun;10(3):143-52. doi: 10.1310/hct1003-143.

PMID:
19632953
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Cytomegalovirus rather than HIV triggers the outgrowth of effector CD8+CD45RA+CD27- T cells in HIV-1-infected children.

Bekker V, Bronke C, Scherpbier HJ, Weel JF, Jurriaans S, Wertheim-van Dillen PM, van Leth F, Lange JM, Tesselaar K, van Baarle D, Kuijpers TW.

AIDS. 2005 Jul 1;19(10):1025-34.

PMID:
15958833
[PubMed - indexed for MEDLINE]
11.

Human cytomegalovirus (HCMV)-specific CD4+ T lymphocyte response in AIDS patients with no past or current HCMV disease following HAART.

Tamarit A, Alberola J, Mir A, Benet I, Mira JV, Muñoz C, Galindo MJ, Navarro D.

J Clin Virol. 2004 Apr;29(4):308-14.

PMID:
15018860
[PubMed - indexed for MEDLINE]
12.

Infrequent detection of HIV-1-specific, but not cytomegalovirus-specific, CD8(+) T cell responses in young HIV-1-infected infants.

Scott ZA, Chadwick EG, Gibson LL, Catalina MD, McManus MM, Yogev R, Palumbo P, Sullivan JL, Britto P, Gay H, Luzuriaga K; PACTG(Pediatric AIDS Clinical Trial Group) 345 Investigators.

J Immunol. 2001 Dec 15;167(12):7134-40.

PMID:
11739536
[PubMed - indexed for MEDLINE]
Free Article
13.

Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment.

Alfonzo M, Blanc D, Troadec C, Eliaszewicz M, Gónzalez G, Scott-Algara D.

Scand J Immunol. 2003 Apr;57(4):375-83.

PMID:
12662301
[PubMed - indexed for MEDLINE]
14.

[Predictors of progression and death in patients with advanced HIV infection in the era of highly active antiretroviral therapy].

Reus S, Portilla J, Gimeno A, Sánchez-Payá J, García-Henarejos JA, Martínez-Madrid O, Usó J, Roca B, Galindo MJ, López-Aldeguer J.

Enferm Infecc Microbiol Clin. 2004 Mar;22(3):142-9. Spanish.

PMID:
14987534
[PubMed - indexed for MEDLINE]
15.

Shift of CMV-specific CD4+ T-cells to the highly differentiated CD45RO-CD27- phenotype parallels loss of proliferative capacity and precedes progression to HIV-related CMV end-organ disease.

Bronke C, Jansen CA, Westerlaken GH, De Cuyper IM, Miedema F, Tesselaar K, van Baarle D.

Clin Immunol. 2007 Aug;124(2):190-9. Epub 2007 Jun 6.

PMID:
17556025
[PubMed - indexed for MEDLINE]
16.

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.

Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.

J Infect Dis. 2001 Apr 15;183(8):1285-9. Epub 2001 Mar 12.

PMID:
11262214
[PubMed - indexed for MEDLINE]
Free Article
17.

Kinetics of interferon-gamma producing cytomegalovirus (CMV)-specific CD4+ and CD8+ T lymphocytes and the risk of subsequent CMV viremia after allogeneic hematopoietic stem cell transplantation.

Eid AJ, Brown RA, Hogan WJ, Lahr BD, Eckel-Passow JE, Litzow MR, Razonable RR.

Transpl Infect Dis. 2009 Dec;11(6):519-28. doi: 10.1111/j.1399-3062.2009.00446.x. Epub 2009 Sep 9.

PMID:
19744286
[PubMed - indexed for MEDLINE]
18.

Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.

Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM.

J Infect Dis. 2001 May 1;183(9):1399-404. Epub 2001 Mar 30.

PMID:
11294673
[PubMed - indexed for MEDLINE]
Free Article
20.

[The prognostic value of cytomegalovirus antigenemia and viremia for the development of cytomegalovirus disease and the survival of AIDS patients].

Cartón JA, Maradona JA, de Oña M, Asensi V, Melón S, García-Alcalde ML, Rodríguez-Junquera M, Moreno-Torrico A, de Zárraga M.

Med Clin (Barc). 1999 Sep 4;113(6):205-9. Spanish.

PMID:
10472608
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk